ACHE and Alzheimer disease: AD is associated with acetylcholine depletion in the brain, which is due to acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) catalytic activities [24], thereby making AChE and BChE potential targets for drug design in the management of AD.